Nevertheless, downregulation of LEF1-AS1 correlates positively with tumor progression in patients with myelodysplastic syndrome and acute myeloid malignancy, indicating a tumor suppressive role in myeloid malignancy [90]. The gene discussed is LEF1; the disease is neoplasm.